QTc prolongation and drugs.
Henderson
W
W
Chu
J
J
Hoffman
R
R
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000009:adverse effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D017336:Loratadine / Q000009:adverse effects*; D010089:Oxidoreductases, N-Demethylating / Q000378:metabolism; D010879:Piperazines; D014230:Triazoles / Q000009:adverse effects*
D018687:Antidepressive Agents, Second-Generation; D006634:Histamine H1 Antagonists; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone; D017336:Loratadine; D003577:Cytochrome P-450 Enzyme System; D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D010089:Oxidoreductases, N-Demethylating